SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-05-000370
Filing Date
2005-11-07
Accepted
2005-11-04 19:46:21
Documents
5
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a14126e10vq.htm 10-Q 167314
2 EXHIBIT 10.5 a14126exv10w5.htm EX-10.5 60384
3 EXHIBIT 31.1 a14126exv31w1.htm EX-31.1 8668
4 EXHIBIT 31.2 a14126exv31w2.htm EX-31.2 8666
5 EXHIBIT 32.1 a14126exv32w1.htm EX-32.1 5367
  Complete submission text file 0000936392-05-000370.txt   251806
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 051181810
SIC: 2836 Biological Products, (No Diagnostic Substances)